Patents by Inventor Keishi MIYATA

Keishi MIYATA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for treating or preventing heart failure
    Patent number: 11235073
    Abstract: A pharmaceutical composition can be provide for treating or preventing heart failure. Additionally, siRNA and a vector expressing said siRNA can be provided that can be used in the pharmaceutical composition for treating or preventing heart failure. For example, a pharmaceutical composition can be provided for treating or preventing heart failure that contains a DNA sequence encoding RNA containing a sense strand sequence of consecutive 18 to 29 nucleotides from angiopoietin-like protein 2 (ANGPTL2) mRNA or the alternative splicing type RNA thereof and an antisense strand sequence complementary to the sense strand sequence under control of a promoter, and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: March 23, 2020
    Date of Patent: February 1, 2022
    Assignee: NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY
    Inventors: Yuichi Oike, Tian Zhe, Tsuyoshi Kadomatsu, Keishi Miyata, Haruki Horiguchi
  • PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HEART FAILURE
    Publication number: 20190022250
    Abstract: A pharmaceutical composition can be provide for treating or preventing heart failure. Additionally, siRNA and a vector expressing said siRNA can be provided that can be used in the pharmaceutical composition for treating or preventing heart failure. For example, a pharmaceutical composition can be provided for treating or preventing heart failure that contains a DNA sequence encoding RNA containing a sense strand sequence of consecutive 18 to 29 nucleotides from angiopoietin-like protein 2 (ANGPTL2) mRNA or the alternative splicing type RNA thereof and an antisense strand sequence complementary to the sense strand sequence under control of a promoter, and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: November 2, 2016
    Publication date: January 24, 2019
    Inventors: Yuichi OIKE, Tian ZHE, Tsuyoshi Mary KADOMATSU, Keishi MIYATA, Haruki HORIGUCHI